Antonio La Cava

Title(s)Professor-in-Residence, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Autoantibody blockade in neonatal lupus
    NIH R21AI154935May 22, 2020 - Apr 30, 2022
    Role: Principal Investigator
    Antibody-mediated suppression of autoimmunity in humanized mice
    NIH R21HD097531Mar 17, 2019 - Feb 28, 2021
    Role: Principal Investigator
    Leptin and mTOR: metabolic partners in autoimmunity
    NIH R21AI109677Jul 1, 2015 - Jun 30, 2018
    Role: Principal Investigator
    Sexual Dimorphism and Dysregulated Immune Responses in SLE: The Role of Leptin
    NIH R21AI095921Aug 18, 2011 - Jul 31, 2013
    Role: Principal Investigator
    Role of Leptin in Systemic Lupus Erythematosus
    NIH R01AR053239Aug 1, 2006 - Jun 30, 2012
    Role: Principal Investigator
    Leptin-based intervention in systemic autoimmunity
    NIH R21AI063515Apr 1, 2005 - Mar 31, 2008
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Antiphospholipid antibodies and COVID-19. Autoimmun Rev. 2021 10; 20(10):102910. La Cava A. PMID: 34303846.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Editorial overview: Research progress in autoimmunity: an overview and update. Curr Opin Immunol. 2020 12; 67:iii-v. La Cava A. PMID: 33323175.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. The Influence of Diet and Obesity on Gene Expression in SLE. Genes (Basel). 2019 05 27; 10(5). La Cava A. PMID: 31137916.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Tregs in SLE: an Update. Curr Rheumatol Rep. 2018 02 21; 20(2):6. La Cava A. PMID: 29464438.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    5. Leptin in inflammation and autoimmunity. Cytokine. 2017 10; 98:51-58. La Cava A. PMID: 27916613.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimals
    6. Targeting the BLyS-APRIL signaling pathway in SLE. Clin Immunol. 2013 Sep; 148(3):322-7. La Cava A. PMID: 23269199.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    7. Proinflammatory activities of leptin in non-autoimmune conditions. Inflamm Allergy Drug Targets. 2012 Aug 01; 11(4):298-302. La Cava A. PMID: 22458591.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    8. Adiponectin: a relevant player in obesity-related colorectal cancer? Gut. 2013 Apr; 62(4):483-4. La Cava A. PMID: 22851665.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    9. Targeting B cells with biologics in systemic lupus erythematosus. Expert Opin Biol Ther. 2010 Nov; 10(11):1555-61. La Cava A. PMID: 20919800.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    10. Modulation of autoimmunity with artificial peptides. Autoimmun Rev. 2010 Nov; 10(1):18-21. La Cava A. PMID: 20807590.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    11. Anticytokine therapies in systemic lupus erythematosus. Immunotherapy. 2010 Jul; 2(4):575-82. La Cava A. PMID: 20636010.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    12. The busy life of regulatory T cells in systemic lupus erythematosus. Discov Med. 2009 Jun; 8(40):13-7. La Cava A. PMID: 19772836.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    13. Lupus and T cells. Lupus. 2009 Mar; 18(3):196-201. La Cava A. PMID: 19213856.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    14. Natural Tregs and autoimmunity. Front Biosci (Landmark Ed). 2009 Jan 01; 14:333-43. La Cava A. PMID: 19273070.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    15. Immunotherapy with peptides in systemic lupus erythematosus. Curr Med Chem. 2009; 16(12):1482-8. La Cava A. PMID: 19355901.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    16. Tregs are regulated by cytokines: implications for autoimmunity. Autoimmun Rev. 2008 Oct; 8(1):83-7. La Cava A. PMID: 18771756.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    17. T-regulatory cells in systemic lupus erythematosus. Lupus. 2008 May; 17(5):421-5. La Cava A. PMID: 18490420.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    18. CD4+CD25+ Tregs and NKT cells: regulators regulating regulators. Trends Immunol. 2006 Jul; 27(7):322-7. La Cava A, Van Kaer L, Fu-Dong-Shi . PMID: 16735139.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansAnimalsCells
    19. Natural and adaptive immune cell-based therapies in autoimmunity. Curr Med Chem. 2006; 13(13):1557-66. La Cava A, Shi FD. PMID: 16787203.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    20. Manipulation of immune regulation in systemic lupus erythematosus. Autoimmun Rev. 2005 Nov; 4(8):515-9. La Cava A, Fang CJ, Singh RP, Ebling F, Hahn BH. PMID: 16214088.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    21. Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA. J Immunol. 2004 Sep 01; 173(5):3542-8. La Cava A, Ebling FM, Hahn BH. PMID: 15322219.
      View in: PubMed   Mentions: 36     Fields:    Translation:AnimalsCells
    22. The weight of leptin in immunity. Nat Rev Immunol. 2004 May; 4(5):371-9. La Cava A, Matarese G. PMID: 15122202.
      View in: PubMed   Mentions: 253     Fields:    Translation:HumansCells
    23. Leptin-based immune intervention: current status and future directions. Curr Opin Investig Drugs. 2003 Nov; 4(11):1327-32. La Cava A, Matarese G, Ebling FM, Hahn BH. PMID: 14758772.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    Antonio's Networks
    Concepts (69)
    Derived automatically from this person's publications.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-866-g4098221c on PROFILES-PWEB02.

    Copyright © The Regents of the University of California